Source:http://linkedlifedata.com/resource/pubmed/id/19390947
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-4-24
|
pubmed:abstractText |
We compared standardized uptake values (SUVs) on positron emission tomography with a glucose analog, 2-[F-18] fluoro-2-deoxy-D-glucose (FDG-PET) and serum soluble interleukin-2 receptor (sIL-2R) values in patients with non-Hodgkin's lymphoma (NHL) in the pre-, mid- (after three or four cycles), and post-treatment periods of chemotherapy (pre, mid, and post, respectively), and we examined whether the SUV was a useful tumor marker for NHL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1341-9625
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
150-8
|
pubmed:meshHeading |
pubmed-meshheading:19390947-Aged,
pubmed-meshheading:19390947-Female,
pubmed-meshheading:19390947-Fluorodeoxyglucose F18,
pubmed-meshheading:19390947-Humans,
pubmed-meshheading:19390947-Lymphoma, Non-Hodgkin,
pubmed-meshheading:19390947-Male,
pubmed-meshheading:19390947-Middle Aged,
pubmed-meshheading:19390947-Positron-Emission Tomography,
pubmed-meshheading:19390947-Radiopharmaceuticals,
pubmed-meshheading:19390947-Receptors, Interleukin-2
|
pubmed:year |
2009
|
pubmed:articleTitle |
Standardized uptake value on FDG-PET as a marker for disease activity in patients with non-Hodgkin's lymphoma: comparison with serum soluble interleukin-2 receptor values.
|
pubmed:affiliation |
Department of Nuclear Medicine, Osaka University Graduate School of Medicine, 2-2-D9 Yamadaoka, Suita, Osaka, 565-0871, Japan. m-tatsumi@radiol.med.osaka-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study
|